Clinical TrialID 8201
The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.
NCT05781633
Mammary Neoplasms, Human
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 8201
- Evidence Id
- 8201
- Core Evidence Id
- 8201
- Source Clinical Trial Id
- 8199
- Herb2 Clinical Trial Id
- HBCT008199
- Nct Id
- NCT05781633
- Title
- The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.
- Status
- Recruiting
- Phase
- Study Result
- No
- Study Condition
- Mammary Neoplasms, Human
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: eutidrone etoposide bevacizumab
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- Female
- Age
- Adult, Older_Adult
- Enrollment
- 43
- Outcome Measure
- CNS Objective response rate (CNS-ORR), The proportion of patients with complete response (CR) and partial response (PR) evaluated as the best response observed from enrollment to progression of all CNS target lesions assessed according to RANO-BM criteria among the total number of patients who could be evaluated., 12 months
- Sponsor Collaborator
- Tianjin Medical University Cancer Institute and Hospital
- Funded By
- OTHER
- Location
- Yehui Shi, Tianjin, Tianjin, 300060, China
- Other Id
- UTD-1-BM-II
- Start Date
- 2022-07-20
- Primary Completion Date
- 2023-07-20
- Completion Date
- 2025-07-20
- First Posted
- 2023-03-23
- Results First Posted
- Last Update Posted
- 2023-03-23
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05781633
- Title Cn
- Title En
- The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.
- Bilingual Status
- semi_complete